Janoštiak Lab
Lisá Z, Fanta M, Kokavec J, Janoštiak R. Global RNA expression analysis of patient samples identified potential diagnostic biomarkers specific for peritoneal, ovarian and deep endometriosis. Sci Rep. 2026 Jan 12;16(1):5070. doi: 10.1038/s41598-026-35467-9. (IF 4.9 Q1) [PubMed]
Csergeová L, Janoštiak R. Dynamic Phosphoproteomic Profiling Identifies Casein Kinase 2 as a Critical Survival Kinase in Quiescent Breast Cancer Cells and a Potential Therapeutic Target for Minimal Residual Disease. Cancers (Basel). 2026 Apr 30;18(9):1449. doi: 10.3390/cancers18091449. (IF 4.8 Q2) [PubMed]
Lisá Z, Janoštiak R, Hlinecká K, Richtárová A, Kužel D, Mára M, Fanta M. Molecular mechanisms leading to fibrosis in endometriosis. Ceska Gynekol. 2025;90(2):167-172. English. doi: 10.48095/cccg2025167. PMID: 40420598. (IF 0.5 / Q4) [PubMed]
2024
Csergeová L, Krbušek D, Janoštiak R. CIP/KIP and INK4 families as hostages of oncogenic signaling. Cell Div. 2024 Apr 1;19(1):11. doi: 10.1186/s13008-024-00115-z. (IF 2.8 / Q3) [Pubmed]
Škarková A, Bizzarri M, Janoštiak R, Mašek J, Rosel D, Brábek J. Educate, not kill: treating cancer without triggering its defenses. Trends Mol Med. 2024 Apr 23:S1471-4914(24)00091-1. doi: 10.1016/j.molmed.2024.04.003. Epub ahead of print. (IF 13.6 / Q1) [PubMed]
Dave J, Jagana V, Janostiak R, Bisserier M. Unraveling the epigenetic landscape of pulmonary arterial hypertension: implications for personalized medicine development. J Transl Med. 2023 Jul 17;21(1):477. doi: 10.1186/s12967-023-04339-5. (IF 6.1 / Q1) [PubMed]
Lerner G, Tang H, Singh K, Golestani R, St Claire S, Humphrey PA, Lannin D, Janostiak R, Harigopal M. AMACR Expression is a Potential Diagnostic Marker in Apocrine Lesions of Breast, and is Associated with High Histologic Grade and Lymph Node Metastases in Some Invasive Apocrine Breast Cancers. Clin Breast Cancer. 2023 Feb;23(2):199-210. doi: 10.1016/j.clbc.2022.11.012. (IF 2.9/ Q2) [PubMed]
Herceg S, Janoštiak R. Diagnostic and Prognostic Profiling of Nucleocytoplasmic Shuttling Genes in Hepatocellular Carcinoma. Folia Biol (Praha). 2023;69(4):133-148. doi: 10.14712/fb2023069040133. (IF 1.1 / Q3) [PubMed]